TGFB1 and neoplasm: A recent study demonstrated that IL-1β-polarized Th17 cells are effector cells against tumors, whereas TGF-β-polarized Th17 cells do not have such a potent antitumor effect, which was attributed to the induction of CD73 by TGF-β to support tumor growth [18,39].